Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2013

  1. Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study

    Neuro-Oncology, Vol. 15, Núm. 9, pp. 1236-1243